Calcichew-D3 Forte Double Strength 1000 mg/800 IU Chewable Tablets
Authorisation PA2239/013/003 · CHEPLAPHARM Arzneimittel GmbH
- Licence holder
- CHEPLAPHARM Arzneimittel GmbH (all products →)
- Active substances
- Calcium carbonate, Cholecalciferol concentrate (powder form)
- Dosage form
- Chewable tablet
- Route of administration
- Oral use
- ATC code
- A12AX
- First authorised
- 11/12/2009
- Prescription status
- Product not subject to medical prescription
- Supply
- Supply through pharmacies only
- Legal basis
- Well-established use application (Article 10a of Directive No 2001/83/EC)
Calcium carbonate: supply and approvals
34 authorised products on the HPRA list contain Calcium carbonate. Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 19 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 19 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 19 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
Cholecalciferol concentrate (powder form): supply and approvals
2 authorised products on the HPRA list contain Cholecalciferol concentrate (powder form). Shortage records below are for the substance in the EU, US and German markets and may not affect this Irish product; for Irish supply, check with the HPRA or a pharmacist.
- EU shortage (EMA)
- No entry in the EMA shortage catalogue (checked 19 Nov 2026)
- US shortage (FDA)
- No entry in the FDA drug shortage list (checked 19 Nov 2026)
- Germany (BfArM)
- No entry in the BfArM supply notices (checked 19 Nov 2026)
Registers: EU shortages · US shortages · German shortages · EMA approvals
About this licence
National authorisation (PA). A product authorisation granted by the HPRA for the Irish market. It has been authorised for 16 years (since 11 December 2009). The HPRA list marks it as marketed in Ireland.
Other medicines with Calcium carbonate in Ireland
33 other products on the HPRA list contain Calcium carbonate, from 12 licence holders; 20 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
Other medicines with Cholecalciferol concentrate (powder form) in Ireland
1 other product on the HPRA list contains Cholecalciferol concentrate (powder form), from 1 licence holder; 0 of them are marked as marketed. Products with the same substance can differ in strength, form, other ingredients and what they are licensed for, so they are not automatically interchangeable.
| Medicine | Licence holder | Licence | Status |
|---|---|---|---|
| Calcichew-D3 Forte Double Strength 1000 mg/800 IU Chewable Tablets | PCO Manufacturing Ltd. | Parallel import (PPA) | Not stated |
Other substances in ATC group A12AX
The ATC system groups medicines by the part of the body they act on and their chemistry. On the HPRA list, 7 other active substances share the group A12AX with this product:
Calcium (5) · Cholecalciferol (4) · Colecalciferol (3) · Cholecalciferol concentrate (2) · Calcium gluconate (1) · Nicotinic acid (1) · Vitamin d3 (1)
Numbers in brackets are products on the HPRA list. Sharing an ATC group does not mean two medicines can replace each other.
The licence holder
CHEPLAPHARM Arzneimittel GmbH holds 74 products on the HPRA list, with 33 different active substances; 44 of the products are marked as marketed.
This listing is regulatory information, not medical advice — consult the package leaflet, SPC, or a healthcare professional. For the authoritative record see the HPRA register.
How this page is built
The facts on this page are pulled directly from the HPRA's (Health Products Regulatory Authority) official open dataset — they are not written from memory, and nothing here is summarised or edited. Each field below names the dataset it came from, so you can check it yourself.
- HPRA Authorised Medicines List (open data) ↗ Licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status for this product
This page is built automatically: a daily sync job downloads HPRA's published XML export and copies the licence number, holder, active substance(s), dosage form, route, ATC code(s), authorisation date and prescription status directly into this page — no AI drafting and no per-product editorial pass. The “last verified” date above is the timestamp of that sync, not a review date. Our general editorial approach is described in our editorial standards and corrections policy. The HPRA data on this page was last retrieved on 20 Nov 2026. How every register is built: methodology · fixes we have made: corrections log.